E
Pharmadrug Inc. PHRX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 24.79% -234.23% 139.19% -38.52% 74.01%
Total Depreciation and Amortization 3.41% -2.22% -2.17% 0.00% -1.08%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 25.50% 161.98% -144.36% 7.29% 137.71%
Change in Net Operating Assets -258.98% 231.28% -177.08% 117.08% -85.59%
Cash from Operations -405.77% -1,140.00% 114.29% 95.32% 62.91%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- -100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -405.77% 16.13% -77.14% 95.32% 7.37%